News Conference News AHA 2012 ASCERT: CABG More Cost-Effective Than PCI Over Long Term Jason Kahn November 05, 2012
Presentation AHA 2012 Rivaroxaban Use is Associated with Reduced Risk of Myocardial Infarction- Insights from a Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials Presenter: Saurav Chatterjee November 04, 2012
Presentation AHA 2012 Results of Exenatide Myocardial Protection In REvascularization (EMPIRE) Study Presenter: Weon Kim November 04, 2012
News Conference News AHA 2012 UMPIRE: Multidrug ‘Polypill’ Improves Adherence, BP, Cholesterol November 04, 2012
News Industry News Significant Blood Pressure Reduction from St. Jude Medical's EnligHTN Renal Denervation Technology is Safe, Effective and Sustained at Six Months November 04, 2012
News Conference News AHA 2012 Platelet Reactivity in Response to Prasugrel Depends on the Test November 04, 2012
News Conference News AHA 2012 EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES Jason Kahn November 04, 2012
News Conference News AHA 2012 Early Study Shows Positive Clinical Results with Novel Renal Denervation Device Jason Kahn November 04, 2012
Presentation AHA 2012 First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndromes Trial: The TRILOGY ACS — Platelet Function Substudy Presenter: Paul A. Gurbel November 04, 2012
Presentation AHA 2012 Economic Outcomes of Percutaneous Coronary Intervention Performed at Sites With and Without On-Site Cardiac Surgery Presenter: Eric L. Eisenstein November 04, 2012
News Conference News AHA 2012 TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes November 04, 2012
News Conference News AHA 2012 Pair of Studies Look at Cost Effectiveness of PCI in Different Populations Jason Kahn November 04, 2012
News Conference News AHA 2012 FREEDOM: CABG Superior to PCI in Diabetic Patients with Multivessel Disease November 04, 2012
News Conference News AHA 2012 ARCTIC: Bedside Platelet Monitoring Fails to Help DES Patients Jason Kahn November 04, 2012
News Industry News PROMUS Element™ and PROMUS Element™ Plus Receive CE Mark Approval for Labeling Update to Include Three-Month Dual Anti-Platelet Therapy October 24, 2012
Presentation TCT 2012 Atrial Fibrillation: 1. CHADS2 vs. CHA2DS2-VASc Risk Assessment. 2. AHA/ACC vs. ACCP/ESC Approach to Stroke Prevention. Presenter: Peter Brady October 23, 2012
News Daily News La Ablación Septal con Alcohol Rivaliza con la Miectomía en el Tratamiento de la Cardiomiopatía Hipertrófica Obstructiva L.A. McKeown October 23, 2012
News Daily News Alcohol Septal Ablation Rivals Myectomy for Obstructive Hypertrophic Cardiomyopathy L.A. McKeown October 23, 2012
News Daily News Un Estudio Plantea Dudas sobre la Necesidad de Realizar Más Pruebas tras Cuadros Resueltos de Dolor Torácico L.A. McKeown September 24, 2012